Minimal inhibitory and mutant prevention concentrations of azithromycin, clarithromycin and erythromycin for clinical isolates of Streptococcus pneumoniae

BACKGROUND: Previous work showed a higher prevalence of macrolide/azalide resistance in provinces of Canada where azithromycin was the major treatment for Streptococcus pneumoniae as compared with regions where clarithromycin was the dominant treatment. These data provided a way to test the mutant s...

Full description

Saved in:
Bibliographic Details
Main Authors: Metzler, Kelli, Drlica, Karl, Blondeau, Joseph M.
Format: Artigo
Language:Inglês
Published: Oxford University Press 2013
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3566671/
https://ncbi.nlm.nih.gov/pubmed/23169894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dks461
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items